ASTI is a guideline-based decision support system to be used in primary care. We analyzed the knowledge modelling carried out in the development of ASTI knowledge base (KB) from French clinical practice guidelines (CPGs) on arterial hypertension management to evaluate the evidence status of therapeutic propositions issued by the system. We defined three status: "evidence-based" (EB) when propositions are graded A, B, or C, "consensus-based" (CB) when propositions are explicitly mentioned in CPGs but supported by professional agreement (grade D), and "non-supported" (NS) when propositions are expert-based and provided by a domain specialist. We compared the distributions of evidence status on the 44,571 theoretical patient profiles extracted from ASTI KB, and on a data set of 435 actual hypertensive patients. Only 8.3% of actual patients, managed by 0.5% of the KB, have an EB profile and 46.9% of patients, managed by 12.6% of the KB, have a CB profile. Thus, there is no CPG recommendation for nearly half of the patients (44.8% have a NS profile).
Download full-text PDF |
Source |
---|
Mol Plant Microbe Interact
January 2025
University of Cologne, Institute for Plant Sciences, Cologne, Germany.
Pathogens manipulate host physiology through the secretion of virulence factors (effectors) to invade and proliferate on the host. The molecular functions of effectors inside plant hosts have been of interest in the field of molecular plant-microbe interactions. Obligate biotrophic pathogens, such as rusts and powdery mildews, cannot proliferate outside of plant hosts.
View Article and Find Full Text PDFBioinformatics
January 2025
Biocomputing Group, University of Bologna, Italy.
Motivation: The knowledge of protein stability upon residue variation is an important step for functional protein design and for understanding how protein variants can promote disease onset. Computational methods are important to complement experimental approaches and allow a fast screening of large datasets of variations.
Results: In this work we present DDGemb, a novel method combining protein language model embeddings and transformer architectures to predict protein ΔΔG upon both single- and multi-point variations.
BMC Health Serv Res
January 2025
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, 21205, USA.
Background: Since the inception of the ASHAs in the year 2005, their work horizons have increased from Reproductive, Maternal, Newborn, Child, and Adolescent health (RMNCH + A), Communicable and Non-Communicable Diseases (CD & NCD) to oral health, ophthalmologic care, and other supportive community level healthcare services. The present literature lacks comprehensive understanding and synthesis of domain-wise knowledge of ASHAs and the factors affecting their knowledge. Therefore, this study aimed to synthesize and collate the relevant evidence to understand the overall knowledge of ASHAs.
View Article and Find Full Text PDFBMC Oral Health
January 2025
Sub-Institute of Public Safety Standardization, China National Institute of Standardization, No.4 Zhichun Road, Haidian District, Beijing, 100191, PR China.
Background: This study aimed to establish a model for predicting the difficulty of mandibular third molar extraction based on a Bayesian network to meet following requirements: (1) analyse the interaction of the primary risk factors; (2) output quantitative difficulty-evaluation results based on the patient's personal situation; and (3) identify key surgical points and propose surgical protocols to decrease complications.
Methods: Relevant articles were searched to identify risk factors. Clinical knowledge and experience were used to analyse the risk factors to establish the Bayesian network.
Exp Hematol Oncol
January 2025
Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430300, China.
Immune checkpoint therapies have spearheaded drug innovation over the last decade, propelling cancer treatments toward a new era of precision therapies. Nonetheless, the challenges of low response rates and prevalent drug resistance underscore the imperative for a deeper understanding of the tumor microenvironment (TME) and the pursuit of novel targets. Recent findings have revealed the profound impacts of biomechanical forces within the tumor microenvironment on immune surveillance and tumor progression in both murine models and clinical settings.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!